The luxury two-seat roadster segment is on the verge of extinction in the US, especially after BMW stopped making the Z4 this year.
BMW is celebrating the 100th anniversary of the legendary Nurburgring racetrack by unveiling six limited-edition models from its M division.
Sarvam AI, a leading player in the field of applied artificial intelligence (AI), has unveiled its latest offering: the "core intelligence factory."
The Great Pyramid of Giza, a 4,500-year-old structure, could hold a secret code that reveals its true purpose.
India's once-booming stock market is losing its sheen among global investors.
At its annual Roblox Developer Conference (RDC), the popular gaming platform unveiled a series of new features.
Apple has hiked the prices of its iPhones in India.
Apple announced a new feature, called Apple Reference Image, to verify the authenticity of photos taken with its iPhone 18 Pro.
Apple has officially launched its first-ever foldable smartphone, the iPhone Duo.
Apple has revealed its latest smartwatch, the Apple Watch Series 12, at an event in Cupertino.
Apple has announced its latest high-end smartwatch, the Apple Watch Ultra 4.
Apple has officially introduced the next generation of its wireless earbuds, the AirPods 5.
Apple has introduced the iPhone 18 Pro and iPhone 18 Pro Max.
India's Serious Fraud Investigation Office (SFIO) has recommended a detailed probe into Xiaomi's business operations in the country.
The National Payments Corporation of India (NPCI) has launched two new agentic artificial intelligence (AI) platforms, AiNxt and Agentic Orchestration & Messaging (AtOM), at the Global Fintech Fest 2026 in Mumbai.
The UK government has announced plans to introduce a new law aimed at preventing children from taking or sharing nude images on mobile devices.
WhatsApp has stopped working on devices running Android 5.0 and 5.1, effective yesterday, a report by WABetaInfo has revealed.
Walmart-backed Flipkart has begun testing its new food delivery service, 'Eat In,' among employees in Bengaluru.
US and Chinese researchers have conducted successful clinical trials of a single-dose nanodrug, which can potentially control "bad" cholesterol levels for years or even forever.
